Mefitel film for radiation dermatitis: it works, why not?

Published Date: 13 Mar 2023

According to the results of a phase 3 trial, the use of silicone film before radiotherapy can reduce the incidence of radiodermatitis, so why not use it?

Read Full News

Latest News

HS Severely Impairs Quality of Life, Even in Mild Disease

Quality of life is severely impaired in patients with hidradenitis suppurativa, including those traditionally classified as having mild disease.

Exclusive-Kennedy Asked to Remove Pennsylvania Measles Death From CDC Tally, Sources Say

U.S. Health Secretary Robert F. Kennedy Jr. asked his new CDC director to remove a reference to two Pennsylvania deaths from the agency’s online measles tally after he...

Better Survival Seen With Spartalizumab Addition in Melanoma

More than 500 adults with BRAF V600-mutant cutaneous melanoma were randomly assigned to receive either intravenous spartalizumab plus oral dabrafenib and trametinib or oral dabrafenib and trametinib.

Advances in MCC: Q&A With Paul Nghiem, MD, PhD

Paul Nghiem, MD, PhD, a global expert in Merkel cell carcinoma, spoke with Medscape Dermatology about recent findings and trends in MCC care and research, as well as a look into the future.

Sofpironium Gel Safety Confirmed in Real-World Use

Real-world surveillance shows adverse events consistent with the known safety profile of sofpironium gel for excessive underarm sweating.

Taking Steps to Reduce Disparities in Women’s Rheumatic Care

Women acquire rheumatic and musculoskeletal diseases more frequently than men. Rheumatologists are working to improve disparities — and overall care — for their female patients.

Todays Updates

‘Modest’ Differences in OAT Should Not Obscure Benefits

Methadone may be linked to a lower risk for death than buprenorphine-naloxone in the short term, but after an overdose, either opioid agonist therapy is better than none.

Talc Powder Not Linked to Lung Cancer in Women

A study of US women finds no connection between talc powder use and lung cancer, though subgroup findings leave questions open.

Todays Updates

‘Modest’ Differences in OAT Should Not Obscure Benefits

Methadone may be linked to a lower risk for death than buprenorphine-naloxone in the short term, but after an overdose, either opioid agonist therapy is better than none.

Talc Powder Not Linked to Lung Cancer in Women

A study of US women finds no connection between talc powder use and lung cancer, though subgroup findings leave questions open.

Latest News

Quality of life is severely impaired in patients with hidradenitis suppurativa, including those traditionally classified as having mild disease.

U.S. Health Secretary Robert F. Kennedy Jr. asked his new CDC director to remove a reference to two Pennsylvania deaths from the agency’s online measles tally after he...

More than 500 adults with BRAF V600-mutant cutaneous melanoma were randomly assigned to receive either intravenous spartalizumab plus oral dabrafenib and trametinib or oral dabrafenib and trametinib.

Paul Nghiem, MD, PhD, a global expert in Merkel cell carcinoma, spoke with Medscape Dermatology about recent findings and trends in MCC care and research, as well as a look into the future.

Real-world surveillance shows adverse events consistent with the known safety profile of sofpironium gel for excessive underarm sweating.

Women acquire rheumatic and musculoskeletal diseases more frequently than men. Rheumatologists are working to improve disparities — and overall care — for their female patients.

News All Time

Vulvar Lichen Sclerosus Affects 1 in 700 US Women

Vulvar lichen sclerosus shows markedly higher rates in women over 60, with White women experiencing the highest burden, a study shows.

Brepocitinib Controls Skin Disease in Dermatomyositis

Brepocitinib produces rapid and sustained improvements in skin disease, itch, and skin-related quality of life in adults with dermatomyositis.

Biologic Choice May Affect PsA Progression in Psoriasis

In patients with psoriasis, interleukin-targeting inhibitors are associated with a lower risk for psoriatic arthritis than TNF inhibitors, a long-term real-world study finds.

ctDNA Detects Postsurgical Merkel Cell Recurrence

Circulating tumor DNA surveillance detects Merkel cell carcinoma recurrence after curative-intent surgery.

Data Gaps Hinder Response to Climate-Driven Infections

Climate change is reshaping infectious disease risk in Italy and beyond, highlighting the need for better diagnostics, integrated data, and stronger global cooperation.

Ruxolitinib Improves Vitiligo Outcomes in Real-World Study

Topical ruxolitinib shows sustained repigmentation through 52 weeks with improvements in anxiety and depression in patients with non-segmental vitiligo.

Longer Targeted Therapy May Not Raise Cancer Risk in SpA

Using targeted therapy for spondyloarthritis for more than 6 months per year is not associated with an increased risk for cancer compared with using targeted therapy for shorter durations.

Clinical Crosstalk: Integrating ICIs and Strengthening Collaborative Care in NMSC

Clinical Crosstalk: Integrating ICIs and Strengthening Collaborative Care in NMSC

In 20 Different Cancers, Men More Likely to Be Diagnosed at a Later Stage

More late-stage diagnoses add to higher cancer mortality burden for men

Viral NeeDoh Trend Leading to Scalding Injuries, Doctors Warn

Kids are microwaving the squishy toy, making the gel inside hot enough to boil and explode

Guidelines Help Spot Dermatomyositis Patients at High Risk for Cancer

IMACS guidelines are clinically useful for identifying high-risk populations, researchers say

What Is the 'Barbie Peptide' and Why Is It Risky?

Dermatologists weigh in on the injectable trend

Fauci's Diaries Released; Cold Brew Recalled; Carly Simon's Diagnosis

Health news and commentary gathered by MedPage Today staff

FDA Staff Unconvinced Drug for Melanoma Shows Benefit

Replimune's RP1 faces tough test at upcoming FDA advisory panel meeting

Antihistamines Panned for Eczema

Network meta-analysis finds no meaningful benefit across the board and some harms

Twice-Rejected Melanoma Drug Gets Love From FDA Panel

Vote at odds with FDA reviewers

Recommended News For You

An understudied type of breast cancer poses a lurking threat

Can Oligonucleotide Infusions Really Fix Lyme, Cancer, and Other Diseases?

Researchers achieve a significant milestone in the management of anemia in chronic lymphocytic leukemia.

Study Finds Microplastics Near Tumors; Experts Doubt Results

Radiotherapy of cancer: Researchers enable better cancer treatment using existing medical equipment

Temsirolimus Plus Chemotherapy Fails in Rare Childhood Cancer

"Unusual" Cancers Following Pandemic; Triumph in TNBC; Clinical Trial Interrupted by Shortage.

Recommended Articles For You

Transformative Practices in Hematology and Quality Improvement 

Clinical Frameworks in Hematology for Better Care 

Metabolic Heterogeneity Driving Tumor Progression 

Emerging Therapies Using Synthetic Hematopoietic Support Systems 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Both men and women who receive the HPV vaccine have a lower risk of developing multiple cancer types.

2.

Base Treatment Decisions in Metastatic Breast Cancer on Presence of ESR1 Mutations

3.

More nonsmokers are getting lung cancer: Oncologist explains why

4.

For the treatment of vestibular schwannomas in neurofibromatosis type 2, stereotactic radiosurgery has been found to be effective.

5.

Psychotropics Linked to Increased BMI, CVD Risk

1.

Modern Oncology Unveiled with Treatment Innovations and Personalized Cancer Care

2.

Cardiotoxicity Beyond Anthracyclines: Redefining Risk in the Cardio-Oncology Era

3.

Clinical Pharmacology of Iron Homeostasis Regulatory Therapeutics

4.

Case Study: Revolutionizing PNH Treatment with Eculizumab for Superior Patient Outcomes

5.

Analyzing the Mechanisms and Efficacy of Carboplatin, Abraxane, and Albumin-Bound Formulations

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Efficient Management of First line ALK-rearranged NSCLC - Part VIII

2.

EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion

3.

Thromboprophylaxis In Medical Settings

4.

An Intro to The Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer Clinical Studies.

5.

Innovations in Hematology

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot